Pleiotropic regulation of macrophage polarization and tumorigenesis by formyl peptide receptor-2

Thrombin facilitates invasion of ovarian cancer along peritoneum by inducing monocyte differentiation toward tumor-associated macrophage-like cells

(2010) Ting Zhang et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Annexin 1 Induced by Anti-Inflammatory Drugs Binds to NF- B and Inhibits Its Activation: Anticancer Effects In vitro and In vivo

(2010) Z. Zhang et al.   CANCER RESEARCH

Fra-1 protooncogene regulates IL-6 expression in macrophages and promotes the generation of M2d macrophages

(2010) Qingshan Wang et al.   CELL RESEARCH

Novel Lipid Mediators Promote Resolution of Acute Inflammation

(2010) Matthew Spite et al.   CIRCULATION RESEARCH

Cancer Therapy By Targeting Hypoxia-Inducible Factor-1

(2010) Y. Li et al.   CURRENT CANCER DRUG TARGETS

IL-23 suppresses innate immune response independently of IL-17A during carcinogenesis and metastasis

(2010) M. W. L. Teng et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Signal Transducer and Activator of Transcription-3, Inflammation, and Cancer

(2009) Bharat B. Aggarwal et al.   Annals of the New York Academy of Sciences

Serum amyloid A

(2009) Emiliano Cocco et al.   CANCER

Regulation of the IL-23 and IL-12 Balance by Stat3 Signaling in the Tumor Microenvironment

(2009) Marcin Kortylewski et al.   CANCER CELL

Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability

(2009) F. Colotta et al.   CARCINOGENESIS

The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment

(2009) A. Greenhough et al.   CARCINOGENESIS

IL-23 signaling enhances Th2 polarization and regulates allergic airway inflammation

(2009) Juan Peng et al.   CELL RESEARCH

Targeted Delivery of Anti-Inflammatory Agents to Tumors

(2009) Maria Coimbra et al.   CURRENT PHARMACEUTICAL DESIGN

Stromal MCP-1 in mammary tumors induces tumor-associated macrophage infiltration and contributes to tumor progression

(2009) Hiroshi Fujimoto et al.   INTERNATIONAL JOURNAL OF CANCER

Interferon-γ reverses the immunosuppressive and protumoral properties and prevents the generation of human tumor-associated macrophages

(2009) Dorothée Duluc et al.   INTERNATIONAL JOURNAL OF CANCER

International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) Family

(2009) R. D. Ye et al.   PHARMACOLOGICAL REVIEWS

Anti-Inflammatory and Proresolving Lipid Mediators

(2008) Charles N. Serhan et al.   Annual Review of Pathology-Mechanisms of Disease

Formyl-peptide receptor like 1: A potent mediator of the Ca2+ release-activated Ca2+ current ICRAC

(2008) Yong-Sheng Li et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

The inflammatory micro-environment in tumor progression: The role of tumor-associated macrophages

(2008) Paola Allavena et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Opposing regulation of neutrophil apoptosis through the formyl peptide receptor-like 1/lipoxin A4 receptor: implications for resolution of inflammation

(2008) Driss El Kebir et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Is serum amyloid A an endogenous TLR4 agonist?

(2008) Silvana Sandri et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Macrophage activation and polarization

(2007) Fernando Oneissi Martinez   Frontiers in Bioscience-Landmark